Wells Fargo & Co. logo

Wells Fargo & Co. (WFC)

Market Closed
5 Dec, 20:00
NYSE NYSE
$
89. 83
-0.38
-0.42%
$
278.21B Market Cap
10.75 P/E Ratio
1.15% Div Yield
8,749,103 Volume
5.15 Eps
$ 90.21
Previous Close
Day Range
89.56 91.11
Year Range
58.42 91.11
Want to track WFC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 39 days
Wells Fargo (WFC) Stock Declines While Market Improves: Some Information for Investors

Wells Fargo (WFC) Stock Declines While Market Improves: Some Information for Investors

Wells Fargo (WFC) concluded the recent trading session at $57.93, signifying a -0.74% move from its prior day's close.

Zacks | 1 year ago
Wells Fargo (WFC) Sued Over $300M Ponzi Scheme Allegations

Wells Fargo (WFC) Sued Over $300M Ponzi Scheme Allegations

Wells Fargo (WFC) faces a class action lawsuit due to its alleged involvement in the $300 million Ponzi scheme from 2011 to 2021.

Zacks | 1 year ago
Wells Fargo (WFC) Unveils New Credit Card With Cashback Feature

Wells Fargo (WFC) Unveils New Credit Card With Cashback Feature

Wells Fargo (WFC) introduces Attune World Elite Mastercard. With 4% unlimited cash rewards on all eligible purchases, the card is likely to stand out among peer offerings.

Zacks | 1 year ago
Time to Buy Stock in These 2 Big Banks

Time to Buy Stock in These 2 Big Banks

Making their way onto the Zacks Rank #1 (Strong Buy) list now appears to be a good time to consider a pair of big bank stocks in Bank of America (BAC) and Wells Fargo (WFC).

Zacks | 1 year ago
Reasons to Add Wells Fargo (WFC) Stock to Your Portfolio Now

Reasons to Add Wells Fargo (WFC) Stock to Your Portfolio Now

Wells Fargo (WFC) will likely gain from strong liquidity and balance sheet position. Also, cost-efficiency initiatives aid bottom-line growth.

Zacks | 1 year ago
Wells Fargo & Company (WFC) is Attracting Investor Attention: Here is What You Should Know

Wells Fargo & Company (WFC) is Attracting Investor Attention: Here is What You Should Know

Wells Fargo (WFC) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Zacks | 1 year ago
Wells Fargo (WFC) Stock Dips While Market Gains: Key Facts

Wells Fargo (WFC) Stock Dips While Market Gains: Key Facts

Wells Fargo (WFC) reachead $59.34 at the closing of the latest trading day, reflecting a -0.97% change compared to its last close.

Zacks | 1 year ago
Wells Fargo Continues To Grow Despite Its Past

Wells Fargo Continues To Grow Despite Its Past

Wells Fargo has faced multiple scandals and asset caps imposed by the FED, but its stock has doubled the returns of the S&P 500 YTD. The company had strong 1Q earnings, with revenue increasing and net income of $4.6 billion, resulting in a low P/E ratio of ~13. Wells Fargo continues to run a major business with diversified consumer and commercial loans, maintaining strong credit quality and the ability to generate substantial shareholder returns.

Seekingalpha | 1 year ago
What Makes Wells Fargo (WFC) a New Strong Buy Stock

What Makes Wells Fargo (WFC) a New Strong Buy Stock

Wells Fargo (WFC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Zacks | 1 year ago
Wells Fargo CEO Charlie Scharf: Regulators Restricting Corporate Lending Business

Wells Fargo CEO Charlie Scharf: Regulators Restricting Corporate Lending Business

Wells Fargo CEO Charlie Scharf reportedly told investors Wednesday (May 29) that the bank could be doing more corporate lending and trading if regulators lifted the asset cap that they imposed on it. Regulators put the $1.

Pymnts | 1 year ago
3 Of My Favorite Names On Wells Fargo's Biotech Buyout List

3 Of My Favorite Names On Wells Fargo's Biotech Buyout List

Wells Fargo recently tagged numerous midcap biotech/biopharma stocks as potential buyout targets. There are many names on this list that have been mentioned as acquisition candidates in the past and that could find themselves in Big Pharma's sights. I highlight three of my favorite equities on Wells Fargo's report that I currently hold in my personal accounts in the paragraphs below.

Seekingalpha | 1 year ago
Wells Fargo's CEO Wants Bank to Manage Its Expenses Better

Wells Fargo's CEO Wants Bank to Manage Its Expenses Better

Charlie Scharf told business leaders that the bank's operating committee agrees on the need for more efficiency.

Barrons | 1 year ago
Loading...
Load More